Epidemiology and molecular pathology at crossroads to establish causation: Molecular mechanisms of malignant transformation

Oncogene

Volumn 23, Issue 38, 2004, Pages 6484-6491

  Bocchetta, Maurizio ^a   Carbone, Michele ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Cell cycle checkpoints; Cell immortalization; Inflammation; Senescence; Tumor suppressor genes

Indexed keywords

CARCINOGEN;

ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL AGING; CELL CYCLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; ENZYME INACTIVATION; EPIGENETICS; GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; GENETICS; NEOPLASM; PATHOLOGY;

ANIMALIA;

CELL AGING; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; ONCOGENES;

EID: 4444334026     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207855     Document Type: Review

References (74)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER and Latif F. (2001). Oncogene, 20, 1509-1518.
2. Ali SH and DeCaprio JA. (2001). Semin. Cancer Biol, 11, 15-23.
3. Al-Zoubi AM, Efimova EV, Kaithamana S, Martinez O, El-Idrissi Mel-A, Dogan RE and Prabhakar BS. (2001). J. Biol. Chem., 276, 47202-47211.
4. Aster J, Pear W, Hasserjian R, Erba H, Davi F, Luo B, Scott M, Baltimore D and Sklar J. (1994). Cold Spring Harb. Symp. Quant. Biol, LIX, 125-136.
5. Balkwill F and Mantovani A. (2001). Lancet, 357, 539-545.
6. Banchereau J and Steinman RM. (1998). Nature, 392, 245-252.
7. Basu S, Binder RJ, Ramalingam T and Srivastava PK. (2001). Immunity, 14, 303-313.
8. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B. (1987). Nature, 327, 293-297.
9. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR. (1997). Nat. Med., 3, 1271-1274.
10. Bryan TM and Reddel RR. (1994). Crit. Rev. Oncog., 5, 331-357.
11. Butel J. (2000). Carcinogenesis, 21, 405-426.
12. Carbone M, Klein G, Gruber J and Wong M: Cancer Res. (in press).
13. Chene P. (2003). Nat. Rev. Cancer, 3, 102-109.
14. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW and DePinho RA. (1999). Cell, 97, 527-538.
15. Clark Jr WH, Elder DE, Guerry IV D, Brahman LE, Trock BJ, Schultz D, Synnestvedt M and Halpern AC. (1989). J. Natl. Cancer Inst., 81, 1893-1904.
16. Collins S and Groudine M. (1982). Nature, 298, 679-681.
17. Coussens LM and Werb Z. (2002). Nature, 420, 860-867.
18. Dammann R, Yang G and Pfeifer GP. (2001). Cancer Res., 61, 3105-3109.
19. DeFeo D, Gonda MA, Young HA, Chang EH, Lowy DR, Scolnick EM and Ellis RW. (1981). Proc. Natl. Acad. Sci. USA, 78, 3328-3332.
20. Diefenbach A and Raulet DH. (2003). Curr. Opin. Immunol., 15, 37-44.
21. Efimova E, Martinez O, Lokshin A, Arima T and Prabhakar BS. (2003). Cancer Res., 63, 8768-8776.
22. Efimova EV, Al-Zoubi AM, Martinez O, Kaithamana S, Lu S, Arima T and Prabhakar BS. (2004). Oncogene. 23, 1076-1087.
23. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD and Sklar J. (1991). Cell, 66, 649-661.
24. Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR and Carbone M. (2002). Oncogene, 21, 1434-1442.
25. Garcia-Rodriguez LA and Huerta-Alvarez C. (2001). Epidemiology, 12, 88-93.
26. Goytisolo FA and Blasco MA. (2002). Oncogene, 21, 584-591.
27. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H and de Lange T. (1999). Cell, 97, 503-514.
28. Hahn WC and Weinberg RA. (2002). Nat. Rev. Cancer, 2, 331-341.
29. Harley CB, Futcher AB and Greider CW. (1990). Nature, 345, 458-460.
30. Hariharan IK and Adams JM. (1987). EMBO J., 6, 115-119.
31. Hayflick L and Moorhead PS. (1961). Exp. Cell. Res., 25, 585-621.
32. Hermeking H. (2003). Nat. Rev. Cancer, 3, 931-943.
33. Hilbert DM, Kopf M, Mock BA, Kohler G and Rudikoff S. (1995). J. Exp. Med, 182, 243-248.
34. Horner SM, DeFilippis RA, Manuelidis L and DiMaio D. (2004). J. Virol., 78, 4063-4073.
35. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ and Beach DH. (1999). J. Exp. Med., 190, 1375-1382.
36. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ and Schreiber RD. (1998). Proc. Natl. Acad. Sci. USA, 95, 7556-7561.
37. Karre K. (2002). Scand. J. Immunol., 55, 221-228.
38. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K. Parsons R, Greenberg N and Ittmann M. (2001). Proc. Natl. Acad. Sci. USA, 98, 11563-11568.
39. Lax I, Kris R, Sasson I, Ullrich A, Hayman MJ, Beug H and Schlessinger J. (1985). EMBO J., 4, 3179-3182.
40. Lee JH, Li YC, Doerre S, Sista P, Ballard DW, Greene WC and Franza Jr BR. (1991). Oncogene, 6, 665-667.
41. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M and Welsh D. (1994). Br. J. Cancer, 69, 409-416.
42. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW. (1998). Genes Dev., 12, 3008-3019.
43. Lin EY, Nguyen AV, Russell RG and Pollard JW. (2001). J. Exp. Med., 193, 727-740.
44. Macip S, Igarashi M, Berggren P, Yu J, Lee SW and Aaronson SA. (2003). Mol. Cell Biol., 23, 8576-8585.
45. Maeda H and Akaike T. (1998). Biochemistry, 63, 854-865.
46. Magee JA, Abdulkadir SA and Milbrandt J. (2003). Cancer Cell, 3, 273-283.
47. Malumbres M and Barbacid M. (2001). Nat. Rev. Cancer, 1, 222-231.
48. McLaughlin ME and Jacks T. (2002). Cancer Cell, 1, 408-410.
49. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G and Balkwill F. (1999). Nat. Med., 5, 828-831.
50. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL and Wu JR. (1988). Proc. Natl. Acad. Sci. USA, 85, 6622-6626.
51. Myohanen SK, Baylin SB and Herman JG. (1998). Cancer Res., 58, 591-593.
52. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H and Ohtani H. (1998). Cancer Res., 58, 3491-3494.
53. Nauts H, Fowler G and Bogatko F. (1953). Acta Med. Scand., 144, S1-S103.
54. Neumann AA and Reddel RR. (2002). Nat. Rev. Cancer, 2, 879-884.
55. Parkin DM, Pisani P, Munoz N and Ferlay J. (1999). Infections and Human Cancer Newton R, Beral V and Weiss RA (eds). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
56. Rangarajan A and Weinberg RA. (2003). Nat. Rev. Cancer, 3, 952-959.
57. Reddel RR. (2000). Carcinogenesis, 21, 477-484.
58. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C and Pandolfi PP. (2003). Science, 299, 259-262.
59. Rundell K and Parakati R. (2001). Semin. Cancer Biol., 11, 5-13.
60. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K and Kerjaschki D. (2002). Am. J. Pathol, 161, 947-956.
61. Schreiber H: Semin. Cancer Biol (in press).
62. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
63. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD. (2001). Nature, 410, 1107-1111.
64. Sharpe AH and Freeman GJ. (2002). Nat. Rev. Immunol., 2, 116-126.
65. Shay JW and Bacchetti S. (1997). Eur. J. Cancer, 33, 787-791.
66. Shay JW, Wright WE and Werbin H. (1991). Biochim. Biophys. Acta. 1072, 1-7.
67. Shiloh Y. (2003). Nat. Rev. Cancer, 3, 155-168.
68. Smyth MJ, Taniguchi M and Street SE. (2000). J. Immunol., 165, 2665-2670.
69. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S and Kuwano M. (2000). Int. J. Cancer, 85, 182-188.
70. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN. (2003). Proc. Natl. Acad. Sci. USA, 100, 2645-2650.
71. Watson JD. (1972). Nat. New Biol., 239, 197-201.
72. Wei W, Hemmer RM and Sedivy JM. (2001). Mol. Cell. Biol., 21, 6748-6757.
73. Wilhelmsen KC, Eggleton K and Temin HM. (1984). J. Virol., 52, 172-182.
74. Wogan GN, Hecht SS, Felton JS, Conney AH and Loeb LA: Sem. Cancer Biol. (in press).